Tests the BioEP device to help doctors decide on epilepsy diagnoses
Tests whether the BioEP tool helps doctors make diagnostic decisions in adults with epilepsy.
Plain-language title generated from the registry record
Registry title: The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy
Key facts
- Where
- Truro and Wolverhampton, United KingdomSee the 2 sites
Where in United Kingdom
- Royal Cornwall Hospitals TrustTruro, United KingdomTaking people
- The Royal Wolverhampton NHS TrustWolverhampton, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Neuronostics Ltd
- Trial code
- NCT06097195
- Record updated
- 21 April 2026
- Original description
Neuronostics plan a prospective multisite trial to determine the clinical utility of BioEP in the context of diagnostic decision making. Neuronostics will use findings from the trial to improve user experience of the Neuronostics platform (the tool which clinicians use to obtain a BioEP score from EEG and the aligned report). The data coming from the trial will also enable Neuronostics to iterate the BioEP algorithms and so improve future performance.Read full original descriptionShow less
A Multi-centre, Prospective, Two-arm Randomised Controlled Trial to Determine the Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy
Neuronostics plan a prospective multisite trial to determine the clinical utility of BioEP in the context of diagnostic decision making. Neuronostics will use findings from the trial to improve user experience of the Neuronostics platform (the tool which clinicians use to obtain a BioEP score from EEG and the aligned report). The data coming from the trial will also enable Neuronostics to iterate the BioEP algorithms and so improve future performance.
Inclusion: Adult (age 18 and above) presenting with first suspected seizure(s); Able to give informed consent; Patient receives EEG following clinicians' decision to refer for an EEG based on clinical history and seizure description taken during first seizure clinic; Non-contributory EEG only (i.e. no specific diagnostic abnormalities present such as interictal epileptiform discharges).
Exclusion: Participants that upon history taking have a clear clinical diagnosis of a physical condition other than epilepsy (e.g. vasovagal syncope); Participants unable to tolerate an EEG test so no EEG data were gathered; Participants with a known hepatic/renal encephalopathy.